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ABSTRACT
Purpose: Ischemia-reperfusion lesions are a form of acute inflammation in which leukocytes are considered to play a pivotal
role. This study was made with the objective of determining whether the blockage of intracellular adhesion molecule-1, involved
in the diapedesis of leukocytes, is efficacious in minimizing this lesions in the skeletal musculature of the posterior limbs of rats.
Methods: The juxta-infrarenal aorta of three groups of six adult rats was clipped for six hours. After this, one group was
sacrificed (control group) and the others underwent 24 hours of reperfusion, one with 0.9% physiological saline (reperfusion
group) and the other with anti-ICAM-1 monoclonal antibodies (ICAM-1 group). A myeloperoxidase assay was utilized for
estimating the infiltrate of neutrophils. Biopsies were obtained to make thin sections of hematoxylin-eosin and NADH. Blood
samples were collected for making assays of biochemical parameters (creatinine; potassium; DHL; leukogram; venous pH; CK).
Results: The myeloperoxidase levels were raised in the reperfusion (p < 0.001) and ICAM-1 (p < 0.019) groups in relation to the
control group. The oxidative activity of the muscle fibers was significantly raised in the groups that underwent reperfusion. The
other parameters did not present significant differences. Conclusions: The reperfusion lesion was bigger than the ischemic
lesion. There was an increase in oxidative activity and inflammatory infiltrate with the reperfusion, without significant muscle
necrosis being seen under the optical microscope. The blockage of ICAM-1 diminished the inflammatory infiltrate but not the
rise in oxidative activity observed with the reperfusion.
Key words: Ischemia. Reperfusion. Intercellular Adhesion Molecule-1. Muscle, Skeletal. Myeloperoxidase. NADH.
                    Diaphorase.
RESUMO
Objetivo: As lesões de isquemia-reperfusão (I/R) são uma forma de inflamação aguda na qual os leucócitos são considerados
como tendo um papel fundamental. Este estudo foi feito com o objetivo de determinar se o bloqueio das Moléculas de Adesão
Intercelular –1 (ICAM-1), envolvidas na diapedese dos leucócitos, é eficaz em minimizar estas lesões na musculatura esquelética
dos membros posteriores de ratos. Métodos: A aorta infra-renal de três grupos de seis ratos adultos foi clampeada por seis horas.
Logo após, um grupo foi sacrificado (grupo controle) e os outros foram submetidos a 24 horas de reperfusão, um com solução
salina fisiológica 0,9% (grupo reperfusão) e outro com anticorpos monoclonais anti-ICAM-1 (grupo ICAM-1). A quantificação
da enzima mieloperoxidase foi utilizada para estimar o infiltrado de leucócitos na musculatura. Biópsias foram obtidas e coradas
com hematoxilina-eosina e NADH. Amostras de sangue foram obtidas e parâmetros bioquímicos foram analisados (creatinina;
potássio; DHL; leucograma; pH venoso, CK). Resultados: Os níveis de mieloperoxidase foram aumentados nos grupos reperfusão
(p<0,001) e ICAM-1 (p<0,019) em relação ao grupo controle. A atividade oxidativa das fibras musculares foi  aumentada de
maneira significativa nos grupos submetidos a reperfusão. Os outros parâmetros não apresentaram diferenças significativas.
Conclusões: A lesão de reperfusão foi de maior magnitude que a lesão isquêmica. Houve aumento da atividade oxidativa e do
infiltrado inflamatório com a reperfusão, não se observando necrose significativa da musculatura com o microscópio óptico. O
bloqueio de ICAM-I diminuiu o infiltrado inflamatório mas não o aumento da atividade oxidativa observado com a reperfusão.
Descritores: Isquemia. Reperfusão. Molécula 1 de Adesão Intercelular. Músculo esquelético. Peroxidase. NADH.
                   Desidrogenase.
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Introduction
The restoration of blood flow to an extremity that has
undergone acute ischemia initiates a series of events that may
determine a significant deterioration of the lesion, multiple
organ failure and death 1-3. This paradox of the increase in the
lesion with the restitution of oxygenation and vital nutrients to
the cell is still not completely understood today and probably
has a multifactorial etiology 4.
At the end of the 1980’s, a large number of authors
demonstrated beneficial effects on the skeletal musculature of
animal models that underwent ischemia when the reperfusion
was done using blood depleted in neutrophils 5-9. Simulta-
neously, the identification of a congenital deficiency in a fam-
ily of proteins present in leukocyte membranes which is re-
sponsible for the adherence of leukocytes to the endothelium
iniciated the interest in the study of these molecules10. During
this past decade, there has been great emphasis on the block-
age of these adhesion molecules, which may be localized in
leukocytes and/or endothelium, with the objective of minimiz-
ing I/R lesions 11-23. Today, it is believed that signs are gener-
ated at the inflammation sites that activate the circulating ph-
agocytes and the adjacent endothelium. As a consequence of
the activation, one or both of the cell types become adhesive.
The circulating leukocytes then rolling the endothelium, ad-
here firmly to it and migrate through the subendothelial ma-
trix to reach the inflammation sites, where they release cytokines
and lithic substances. This process, despite being essential to
the organism’s defense mechanisms, may sometimes have
pathological consequences 24,25.
Intercellular Adhesion Molecule-1 (ICAM-1), initially
described by Rothlein et al. 26, is one of these adhesion mol-
ecules, expressed in the endothelium 27 and responsible for the
firm adhesion of leukocytes to it.
The objective of this work was to evaluate whether
the blockage of ICAM-1, via the use of monoclonal antibodies
administered at the outset of reperfusion, is efficacious in mini-
mizing reperfusion lesions in the skeletal musculature of rats
undergoing six hours of partial ischemia of the posterior limbs
followed by 24 hours of reperfusion.
Methods
The study utilized 32 adult Wistar EPM-1 rats of
UNIFESP-EPM animal colony. They were aged between 90
and 120 days, and weighed between 250 and 350 g. Ethical
principles for animal experimentation as stated by the Interna-
tional Animal Protection Union and Law 6638 of May 1979,
and revised in 1983 were strictly followed. A protocol was sub-
mitted to the Ethics in Research Committee of UNIFESP-EPM,
and approved under registration n. 204/00.
Surgical technique - Eighteen animals received a pre-
anesthetic dose of ethyl ether and were then completely anes-
thetized using chloral hydrate 10% (0.4 ml/Kg) by peritoneal
route. After abdominal trichotomy and antisepsis using topical
iodopovidine, a median 5 cm laparotomy was carried out, mov-
ing the bowel to the right. The juxta-infrarenal portion of the
abdominal aorta was identified, isolated and ligated using 7-
zero polypropylene thread. The whole procedure was performed
with the assistance of a microscope viewer (DF Vasconcellos,
bench model, series: 51314), at 25x magnification. Ligature
efficacy was verified by the paleness of the hind limbs and the
absence of pulse below the ligature, using the microscope
viewer. Thereafter, the intestines were repositioned in the cav-
ity and the abdominal wall was closed using 3-zero cotton thread
in a continuous single-plane suture.
Randomization of the animals - Six hours later the
animals were re-operated and a random selection was performed
via sealed envelopes to divide the animals into three Groups of
6 rats.
Group I (group control): Without removing the liga-
ture of the aorta, 3 ml of blood was collected from the animal’s
inferior vena cava. Next, two samples of the gastrocnemius
muscle was withdrawn from the left hind limb. Euthanasia
was performed by anesthetic overdose.
Group II (group reperfusion): The ligature of the
animal’s aorta was undone, allowing reperfusion of the hind
limbs. The vena cava inferior was puncionated and 3 ml of
0,9% physiological saline was infused into the vena. The bowel
was again positioned and the abdomen closed. Twenty-four
hours later, the animals were again anesthetized, reopened and
3 ml blood were collected from the inferior vena cava. Two
samples were removed from the gastrocnemius muscle of the
left hind limb. Euthanasia was performed by anesthetic over-
dose.
Group III (group ICAM-1): Procedures were exactly
the same as in Group II, up to the phase of the infusion of 1 ml
of 0.9% physiological saline into the inferior vena cava, after
the second laparotomy. In this Group, anti-ICAM-1 antibodies
(ICN Biomedicals, Inc. – clone 1A29; cat no. 69-627; lot no.
75606; control R37) were added and diluted to a concentration
of 2 ml/kg in 3 ml of 0.9% physiological saline. From this
point on, the procedure was again identical to that of Group II.
Laboratory tests - The blood obtained from inferior
vena cava was separated in three recipients. In a tube with anti
coagulant (EDTA), one ml was added to leukogram and differ-
ential counting; 1½ ml were added in a dry tube to
creatinephosphokinase (CK in unit/L), lactic dehydrogenase
(LDH in unit/L), potassium (K in mEq/L) and creatinine (C in
mg/dl) dosage; and 0,5 ml was added in a heparinized syringe
to pH measurement.
The leukogram was performed in an automated laser
flux cytometry analyzer (Cell Dyn 3700 or 4000) and the dif-
ferential confirmed by reading of a microslide stained by giemsa.
To access the pH, the sample was submitted to a selective ion
technique on a gas analyzer-ABL5 Radiometer®. The reserved
blood from the dry tube was centrifuged at 3000 rpm for 4 mi,
and the plasma separated. Automatic and specific laboratory
analyzer machines made all dosages. Potassium was accessed
by selective ion method on a Hitachi 917- Roche®. Creatinine,
CK and DHL were accessed by enzymatic method on a Hitachi
917- Roche®. All reagents were Roche®, specific to the reac-
tions on these laboratory machines.
Organ samples - Two 1 mm samples from the gas-
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trocnemius of the left hind limb were taken, weighed and fro-
zen at  –80 ºC for myeloperoxidase analysis.
Extraction of myeloperoxidase was taken from the tis-
sue - The material was defrosted at room temperature and 0.5
ml of the cell membrane detergent HTBA (cetyldimethylethyl-
ammonium bromide; L-5335; lot 26H03542; Sigma) was added
for 20 min. The samples were homogenized and incubated of
60º C for two hours to optimize the enzymatic extraction and
inhibit proteases exogens. Thereafter, the material was centri-
fuged at 10,000 rpm for 20 min; the supernatant was separated
and snap frozen at –80 ºC for later enzyme reading using a
spectrophotometer.
Tissue Myeloperoxidase reading - The supernatant of
the homogenized material was defrosted and 450 µl of TMB
(3,4,5-trimethoxybenzoic acid, 8-diethylamine-octyl ester) -
liquid substrate for Elisa (Dako) were added and then read on
a 650-nm spectrophotometer. The results were plotted on a ref-
erence curve, on the myeloperoxidase axis, and the correspond-
ing numbers of neutrophils were found on the other axis. The
numbers found were then divided by the previously recorded
weight of the material, thereby obtaining the concentration of
neutrophils by weight for each tissue of each Group studied.
MPO reference curve - The total blood from 14 nor-
mal rats was collected in heparinized tubes. The polymorpho-
nuclear neutrophils (PMNs) were separated into a 50ml plas-
tic beaker containing a cell sedimentation filter layer made up
of 8 volumes 2% methylcellulose (Sigma) and 5 volumes
34%sodium hypaque  (Sanofi Winthrop). After 20 min at room
temperature (RT), 50% of the plasma layer with a high amount
of leukocytes and platelets was transferred to a plastic tube,
which was centrifuged at 1000 rpm for 10 min at RT. The su-
pernatant plasma, with a high amount of platelets, was dis-
carded and the cell sediment was carefully resuspended in PBS
pH 7.2 and centrifuged twice at 1000 rpm for 10 min. The
supernatant was discarded and the cell sediment was mixed
with 2 ml previously chilled hemolysis solution (NH4CL: 8.29
g/l + KHCO3: 1.0 g/L – Merck S.A.) and kept at 4 ºC for 5 min.
The tube was again centrifuged at 1000 rpm for 10 min at RT,
the supernatant was discarded and the cells were resuspended
in PBS and centrifuged at 1000 rpm at RT. The cells were then
resuspended in 1 ml PBS. The PMNs were counted in a
Neubauer chamber, yielding a concentration of 7.5x106 cells/
ml. The technique was that described by Bradley 24 and
Schierwagen 55 with few modifications.
Muscle biopsies: Fragments of the gastrocnemius were
obtained after the sacrifice of the animals. They were placed in
dry ice and frozen in liquid nitrogen. The period between its
removal and freezing did not exceed fifteen minutes. Two thin
sections were made from each biopsy: hematoxylin-eosin (HE)
and NADH (B-nicotinamide adenine dinucleotide + nitroblue
tetrazolium Grade III; Sigma).
Statistical analysis - ANOVA® method for the analy-
sis of multiple variables was used. Values of p ≤ 0.05, confi-
dence interval of 95%, were considered statistically signifi-
cant.
Results
MPO: For the construction of the calibration curve
(Figure 1), we utilized the number of neutrophils counted in
the Neubauer chamber at the different dilutions, and the re-
spective optical density of the reading from the spectropho-
tometer.
FIGURE 1 – Graph with the interpoled values on the calibration
curve
FIGURE 2 – No statistical difference between animals in the same
Group was observed, however there was a significant increase in the
readings from the animals of Group Reperfusion to the animals of
Group Ischemia (p<0,001) and Group ICAM-1 (p<0,001). When com-
paring Groups Ischemia and ICAM-1, a greater concentration of de-
fense cells in the latter was observed (p<0,019)
The analysis of the levels of MPO enzyme contained
in the gastrocnemius fragments obtained via biopsy demon-
strated that there was a significant increase in MPO levels in
the tissue that underwent reperfusion: control group versus
reperfusion group (p < 0.001) and control group versus ICAM-
1 group (p < 0.019). When we compared the ICAM-1 group
with the reperfusion group, we observed a significant diminu-
tion in the levels of myeloperoxidase (p < 0.001) in the ICAM-
1 group (Figure 2).
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These results suggest that after ischemia the skeletal
musculature of rats presents significant sequestration of neu-
trophils upon reperfusion which is partially, however signifi-
cantly, diminished with the use of anti-ICAM-1 monoclonal
antibodies for rats.
Muscle biopsies: The histological studies of the muscle
biopsies in relation to the number of necrotic fibers (HE) were
not significantly different between the three groups studied.
The study of oxidative activity in the muscle cells (NADH)
demonstrated a significant increase in activity in the groups
that underwent reperfusion (Figures 3 and 4).
FIGURE 3 – Thin section from the ICAM-1 group, demonstrating an
increase in oxidative activity (NADH x 125)
Discussion
Reperfusion of the skeletal musculature after ischemia
of the lower limbs is associated with mortality that varies from
15 to 52% and an amputation rate from 12 to 22%, despite
success in completing revascularization2. Undoubtedly
reperfusion lesions contribute to these results and, the fact that
such lesions initiate pathological reactions which can become
exacerbated, enabling treatment4,31.
For firm adhesion to occur, interaction between gly-
coproteins of specific membranes, presents in the leukocytes,
and ICAM-1, presents in the endothelial cells, needs to occure.
The glycoproteins are formed by the CD11/CD18 complex con-
stituted by one beta subunit, CD18, and three distinct alpha
subunits, CD11a, CD11b and CD11c, denominated integrins25,34-
36. ICAM-1 is an immunoglobulin from the IgG protein super-
family 27.
ICAM-1 is expressed at low levels in the endothe-
lium. In cultures of endothelial cells from the human umbili-
cal cord, its expression increases when stimulated by agents
like interleukin-1 and tumor necrosis factor alpha37, in a pro-
cess that requires synthesis proteins. The expression increases
until it reaches a peak at 4 hours and, thereafter, it remains at
high levels for more than 24 hours 38. Other substances like
Interferon, phorbol-esters and lipopolysaccharides may also
induce or increase ICAM-1 expression. Even cells that nor-
mally do not express ICAM-1 may do so in the presence of
stimuli 40.
In our study, the administration of anti-ICAM-1 mono-
clonal antibodies right at the start of reperfusion significantly
diminished neutrophil infiltration into muscle tissue after is-
chemia. Our data showing that ICAM-1 blockage diminishes
the inflammatory infiltrate in muscle tissue after ischemia is
in agreement with the majority of studies in the literature 14,17,21-
23. Skejeldal et al. 41 mentioned not having obtained any ben-
eficial effect from the use of anti-neutrophil serum, although
they did not assay the MPO and they chilled the ischemic limb
to 22º Celsius. This latter fact could in itself have been respon-
sible for the results encountered, since chilling the ischemic
limb has as influence as the duration of ischemia in determin-
ing the degree of muscle necrosis 42.
The fact that there was a significant increase in in-
flammatory infiltrate with the reperfusion, despite the use of
antibodies, leads us to believe that other cell adhesion methods
could have served as the migration route for the neutrophils.
Kubes et al. 33 reported that the rolling (dependent of Selectin)
and adhesion (dependent of ICAM-I) are not totally interde-
pendent events. Diamond et al. 37 mentioned that the ligation
sites for ICAM-1 with CD11a and CD11b are distinct and,
depending on the clone of the anti-ICAM-1 antibodies, the li-
gation may be preferential or even specific to just one of these
molecules. Issekutz et al. 43 reported that the joint blockage of
CD11a and CD11b is more effective, since in the absence of
one of these molecules, the other could acquire vicariousness.
This data leads us to ask whether the fact that the significant
increase in inflammatory infiltrate, was due to some specific
process in the action of the antibodies.
These results indicate that the six-hour duration of
the partial ischemia was insufficient to cause significant ne-
crosis and that the reperfusion lesion had a greater magnitude
than the ischemic lesion, showing an increased oxidative ac-
tivity, in the skeletal musculature of the rats posterior limbs.
Electrolyte dosage: We did not observe any differences that
was statistically significant in relation to electrolyte dosage,
muscle lesion markers or renal function between the groups
studied.
FIGURE 4 – Thin section from the ischemia group, demonstrating
standart oxidative  activity (whitin normality) (NADH x 125)
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Our data shows that partial ischemia for six hours did
not determine significant muscle necrosis and are corroborated
by numerous studies in literature 8,9,12,42,45,46. Yokota et al. 8 men-
tioned that in cases where the ischemic injury does not deter-
mine significant muscle necrosis, the reperfusion lesion may
have a greater magnitude than the ischemic lesion. In our work,
we observed that the reperfusion lesion had a greater magni-
tude than the ischemic lesion, not only due to the inflamma-
tory infiltrate but also due to the greater oxidative activity pre-
sented by the muscle cells.
Summers et al. 47 observed that changes in chemotac-
tic activity of the neutrophils in I/R lesions can be observed
even in the absence of any other evidence of lesions under the
optical microscope. Weselcouch et al. 12 and Blebea et al. 44
reported than the first changes observed in skeletal muscles
with reperfusion is an increase in microvascular permeability
and edema, both phenomenas mediated by neutrophils, will
occur without there being evidence of lesions under the optical
microscope.
It is known that NADH is an indicator of oxygen con-
sumption at the mitochondrial level. It has been used for mea-
suring oxidation-reduction in different tissues, with its increase
being related to tissue hypoxia and an increase in oxidative
“stress” of the cells 48-51. Horie et al. 52 reported that the in-
crease in NADH staining in tissue undergoing I/R is associ-
ated with the accumulation of neutrophils in this tissue. In our
work, we observed that the increase in oxidative activity in
muscle cells with reperfusion was significant. However when
we compared the ICAM-1 and reperfusion groups, for which
the difference in MPO levels was significant (p < 0.001), we
did not observe differences in the increase of oxidative activity.
The observation that reperfusion exacerbates the le-
sion, as demonstrated by the increase in oxidative activity and
MPO levels, leads us to question whether the use of the anti-
bodies was efficrat in minimizing the reperfusion lesions. The
histological analysis of the HE thin sections did not demon-
strate any beneficial effect, but perhaps if the duration of is-
chemia had been longer, until the time when muscle necrosis
had become evident, we could have seen some difference. The
levels of MPO enzyme were significantly reduced with the use
of the antibodies (p < 0.001) in relation to the reperfusion group,
with the increase, observed in the ICAM-1 group in relation to
the control group being much less (p < 0.019), despite being
significant. The analysis of the NADH thin sections demon-
strated that there was a clear increase in oxidative activity with
the reperfusion. Although there was not  a tendency for this
increase to be less in the ICAM-1 group, this data leads us to
believe that the use of the antibodies was beneficial.
In summary, this study demonstrates that the block-
age of ICAM-1 may diminish the sequestration of neutrophils
in the skeletal musculature after ischemia, minimizing the
reperfusion lesion. Despite the risk of infection inherent to this
therapy 53,54,our data corroborate the impression that the study
of adhesion molecules, a topic open for research, and the con-
sequent possibility of interfering in the intimate action mecha-
nisms of leukocytes, is a promising therapeutic objective that
may have great usefulness in the future.
Conclusions
The reperfusion lesion was bigger than the ischemic
lesion. There was an increase in oxidative activity and inflam-
matory infiltrate with the reperfusion, without significant
muscle necrosis being seen under the optical microscope. The
blockage of ICAM-1 diminished the inflammatory infiltrate
but not the rise in oxidative activity observed with the
reperfusion.
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